GGrantIndex
Sort

326,823 grants matching clinical trial

PHARMACOGENOMICS OF ARRHYTHMIA THERAPY

$2,761,785
Vanderbilt University · U01 · FY2002 · HL

University of Pennsylvania HIV Clinical Trials Unit

$2,761,412
Ian Frank · University Of Pennsylvania · UM1 · FY2025 · AI

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)

$2,760,701
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · U01 · FY2011 · AI

COMPREHENSIVE CANCER CENTER

$2,760,556
Ohio State University · P30 · FY2003 · CA

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,760,232
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA

Systemic Autoimmunity

$2,759,908
Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR

Indiana University Melvin and Bren Simon Cancer Center Support Grant

$2,759,704
Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2019 · CA

University of Kentucky Markey Cancer Center – Cancer Center Support Grant

$2,759,683
Bernard Mark Evers · University Of Kentucky · P30 · FY2025 · CA

Hormonal, Metabolic and Signaling Interactions in PAH

$2,759,549
James E Loyd · Vanderbilt University Medical Center · P01 · FY2016 · HL

Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene

$2,759,348
William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Center for Clinical and Translational Sciences (CCTS)

$2,759,336
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2012 · TR

Community Clinical Oncology Program

$2,758,979
Charles L Loprinzi · Mayo Clinic Rochester · U10 · FY2010 · CA

HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network

$2,758,876
Daniel K Benjamin · Duke University · U24 · FY2025 · TR

Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men

$2,758,797
Christian Grov · Graduate School Of Public Health And Health Policy · UH3 · FY2024 · AI

Neurobiology of Addiction

$2,758,645
George Koob · National Institute On Drug Abuse · ZIA · FY2023 · DA

Comprehensive Cancer Center Program at Fox Chase

$2,758,277
Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2018 · CA

Upstate Carolina Consortium - Community Oncology Research Program

$2,757,523
James D Bearden · Spartanburg Regional Medical Center · UG1 · FY2021 · CA

Stem Cell Biology And Brain Disease

$2,757,488
Ronald McKay · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Rebuilding Immunity for Survival

$2,757,436
Lee Marshall Nadler · Dana-Farber Cancer Inst · U19 · FY2008 · CA

AAA Disease: Mechanism, Stratification and Treatment

$2,756,828
Ronald L Dalman · Stanford University · P50 · FY2010 · HL

Physical Exercise to Prevent Disability Pilot Study

$2,756,179
University Of Florida · U01 · FY2005 · AG

Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19

$2,756,111
Carl H. June · University Of Pennsylvania · P01 · FY2019 · CA

Epidemiology of Diabetes Interventions and Complications Data Coordinating Center

$2,755,891
John M Lachin · George Washington University · U01 · FY2015 · DK

Data Coordinating Center for the Collaborative Pediatric Critical Care

$2,755,872
Jonathan Michael Dean · University Of Utah · U01 · FY2012 · HD

Heartland Cancer Research NCORP

$2,755,865
Bryan Faller · Decatur Memorial Hospital · UG1 · FY2019 · CA